Showing results (1831-1840 of 3,339) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|January 22, 2022
Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's diseaseSharay E Setti, Nikita Das, James Raymick, et al.Metabolic Brain Disease|January 22, 2022
Epigenetic regulation and autophagy modulation debilitates insulin resistance associated Alzheimer's disease condition in ratsViolina Kakoty, Sarathlal K C, Sunil Kumar Dubey, et al.Metabolic Brain Disease|January 26, 2022
Sodium tanshinone IIA sulfonate improves cognitive impairment via regulating Aβ transportation in AD transgenic mouse modelHui-Han Ma, Can Wan, Lu-Di Zhang, et al.Metabolic Brain Disease|March 1, 1986
Glycerol as an indicator of lipid degradation in bicuculline-induced seizures and experimental cerebral ischemiaW Paschen, W van den Kerchhoff, K A HossmannMetabolic Brain Disease|June 1, 1986
Regional blood-brain barrier transport of glucose after portacaval anastomosisA M Mans, D W Davis, R A HawkinsMetabolic Brain Disease|June 1, 1986
Cerebral metabolic effects of organophosphorus anticholinesterase compoundsA L Miller, M A MedinaMetabolic Brain Disease|September 1, 1986
Restraint stress during late pregnancy in rats elicits early hypermyelination in the offspringR C Wiggins, Z GottesfeldMetabolic Brain Disease|December 1, 1986
Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolismJ Galarraga, D J Loreck, J F Graham, et al.Metabolic Brain Disease|January 31, 2022
Circular RNA circSLC8A1 inhibits the proliferation and invasion of glioma cells through targeting the miR-214-5p/CDC27 axisJiabao Zhu, Xiaobin Liu, Zhonghua Luan, et al.Metabolic Brain Disease|January 31, 2022
Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channelsXian-Tao LiPageof 334